CBD would be considered a natural health product under Canada’s Food & Drugs Act — and not be subject to the federal Cannabis Act — according to a proposal from government agency Health Canada. The strategy is aimed at developing the “market for cannabis health products that would not require practitioner oversight,” the government said.
A new classification, Cannabis Health Products (CHP), would be established that would give producers leeway for making some health claims about their CBD products provided evidence exists to back them up, according to Health Canada.
The designation would in effect create a class of less-regulated, non-intoxicating cannabis products that would be sold in retail locations such as pharmacies, health-food stores, and pet stores.
Stakeholders and the public and may comment on a consultation that frames the proposal through Sept. 3, 2019.
Canada, which only recently opened the market for CBD by allowing farmers to sell hemp flowers and leaves, is expected to emerge as a major global CBD producer.